% alzhub.org library filter
% Source: https://alzhub.org/research?journal=EMBO+molecular+medicine
% 37 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{trares2026-42463545,
  author  = {Trares, Kira and Duman, Deniz and Beyer, Léon and Michaelian, Johannes C and Stocker, Hannah and Holleczek, Bernd and Beyreuther, Konrad and Schöttker, Ben and others},
  title   = {{Predictive value of plasma p-tau217 for Alzheimer's dementia compared to other blood-based biomarkers}},
  journal = {EMBO molecular medicine},
  year    = {2026},
  doi     = {10.1038/s44321-026-00483-9},
  pmid    = {42463545},
  url     = {https://doi.org/10.1038/s44321-026-00483-9}
}

@article{salvado2023-36912178,
  author  = {Salvadó, G. and Ossenkoppele, R. and Ashton, N. J. and Beach, T. G. and Serrano, G. E. and Reiman, E. M. and Zetterberg, H. and Mattsson-Carlgren, N. and others},
  title   = {{Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads}},
  journal = {EMBO molecular medicine},
  year    = {2023},
  doi     = {10.15252/emmm.202217123},
  pmid    = {36912178},
  url     = {https://doi.org/10.15252/emmm.202217123}
}

@article{mattsson2016-27534871,
  author  = {Mattsson, N. and Insel, P. S. and Palmqvist, S. and Portelius, E. and Zetterberg, H. and Weiner, M. and Blennow, K. and Hansson, O. and others},
  title   = {{Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201606540},
  pmid    = {27534871},
  url     = {https://doi.org/10.15252/emmm.201606540}
}

@article{placek2021-33270986,
  author  = {Placek, Katerina and Benatar, Michael and Wuu, Joanne and Rampersaud, Evadnie and Hennessy, Laura and Van Deerlin, Vivianna M and Grossman, Murray and Irwin, David J and others},
  title   = {{Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202012595},
  pmid    = {33270986},
  url     = {https://doi.org/10.15252/emmm.202012595}
}

@article{mattssoncarlgren2021-33949133,
  author  = {Mattsson-Carlgren, N. and Janelidze, S. and Bateman, R. J. and Smith, R. and Stomrud, E. and Serrano, G. E. and Reiman, E. M. and Palmqvist, S. and others},
  title   = {{Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202114022},
  pmid    = {33949133},
  url     = {https://doi.org/10.15252/emmm.202114022}
}

@article{selkoe2016-27025652,
  author  = {Selkoe, Dennis J. and Hardy, John},
  title   = {{The amyloid hypothesis of Alzheimer's disease at 25 years}},
  journal = {EMBO Molecular Medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201606210},
  pmid    = {27025652},
  url     = {https://doi.org/10.15252/emmm.201606210}
}

@article{suarezcalvet2016-26941262,
  author  = {Suárez-Calvet, M. and Kleinberger, G. and MÁ, Araque Caballero and Brendel, M. and Rominger, A. and Alcolea, D. and Fortea, J. and Lleó, A. and others},
  title   = {{sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers}},
  journal = {EMBO molecular medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201506123},
  pmid    = {26941262},
  url     = {https://doi.org/10.15252/emmm.201506123}
}

@article{ewers2020-32790063,
  author  = {Ewers, M. and Biechele, G. and Suárez-Calvet, M. and Sacher, C. and Blume, T. and Morenas-Rodriguez, E. and Deming, Y. and Piccio, L. and others},
  title   = {{Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation}},
  journal = {EMBO molecular medicine},
  year    = {2020},
  doi     = {10.15252/emmm.202012308},
  pmid    = {32790063},
  url     = {https://doi.org/10.15252/emmm.202012308}
}

@article{ossenkoppele2021-34254442,
  author  = {Ossenkoppele, R. and Reimand, J. and Smith, R. and Leuzy, A. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Zetterberg, H. and others},
  title   = {{Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202114398},
  pmid    = {34254442},
  url     = {https://doi.org/10.15252/emmm.202114398}
}

@article{biel2023-36620941,
  author  = {Biel, D. and Suárez-Calvet, M. and Hager, P. and Rubinski, A. and Dewenter, A. and Steward, A. and Roemer, S. and Ewers, M. and others},
  title   = {{sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2023},
  doi     = {10.15252/emmm.202216987},
  pmid    = {36620941},
  url     = {https://doi.org/10.15252/emmm.202216987}
}

@article{palmqvist2019-31709776,
  author  = {Palmqvist, S. and Insel, P. S. and Stomrud, E. and Janelidze, S. and Zetterberg, H. and Brix, B. and Eichenlaub, U. and Dage, J. L. and others},
  title   = {{Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2019},
  doi     = {10.15252/emmm.201911170},
  pmid    = {31709776},
  url     = {https://doi.org/10.15252/emmm.201911170}
}

@article{suarezcalvet2020-33169916,
  author  = {Suárez-Calvet, M. and Karikari, T. K. and Ashton, N. J. and Lantero Rodríguez, J. and Milà-Alomà, M. and Gispert, J. D. and Salvadó, G. and others},
  title   = {{Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected}},
  journal = {EMBO molecular medicine},
  year    = {2020},
  doi     = {10.15252/emmm.202012921},
  pmid    = {33169916},
  url     = {https://doi.org/10.15252/emmm.202012921}
}

@article{schlepckow2020-32154671,
  author  = {Schlepckow, K. and Monroe, K. M. and Kleinberger, G. and Cantuti-Castelvetri, L. and Parhizkar, S. and Xia, D. and Willem, M. and Werner, G. and others},
  title   = {{Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region}},
  journal = {EMBO molecular medicine},
  year    = {2020},
  doi     = {10.15252/emmm.201911227},
  pmid    = {32154671},
  url     = {https://doi.org/10.15252/emmm.201911227}
}

@article{schlepckow2017-28855300,
  author  = {Schlepckow, K. and Kleinberger, G. and Fukumori, A. and Feederle, R. and Lichtenthaler, S. F. and Steiner, H. and Haass, C.},
  title   = {{An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function}},
  journal = {EMBO molecular medicine},
  year    = {2017},
  doi     = {10.15252/emmm.201707672},
  pmid    = {28855300},
  url     = {https://doi.org/10.15252/emmm.201707672}
}

@article{sierksma2020-31951107,
  author  = {Sierksma, A. and Lu, A. and Mancuso, R. and Fattorelli, N. and Thrupp, N. and Salta, E. and Zoco, J. and Blum, D. and others},
  title   = {{Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology}},
  journal = {EMBO molecular medicine},
  year    = {2020},
  doi     = {10.15252/emmm.201910606},
  pmid    = {31951107},
  url     = {https://doi.org/10.15252/emmm.201910606}
}

@article{nabers2018-29626112,
  author  = {Nabers, A. and Perna, L. and Lange, J. and Mons, U. and Schartner, J. and Güldenhaupt, J. and Saum, K. U. and Janelidze, S. and others},
  title   = {{Amyloid blood biomarker detects Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2018},
  doi     = {10.15252/emmm.201708763},
  pmid    = {29626112},
  url     = {https://doi.org/10.15252/emmm.201708763}
}

@article{gotzl2019-31122931,
  author  = {Götzl, J. K. and Brendel, M. and Werner, G. and Parhizkar, S. and Sebastian Monasor, L. and Kleinberger, G. and Colombo, A. V. and Deussing, M. and others},
  title   = {{Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism}},
  journal = {EMBO molecular medicine},
  year    = {2019},
  doi     = {10.15252/emmm.201809711},
  pmid    = {31122931},
  url     = {https://doi.org/10.15252/emmm.201809711}
}

@article{thornton2017-28855301,
  author  = {Thornton, P. and Sevalle, J. and Deery, M. J. and Fraser, G. and Zhou, Y. and Ståhl, S. and Franssen, E. H. and Dodd, R. B. and others},
  title   = {{TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant}},
  journal = {EMBO molecular medicine},
  year    = {2017},
  doi     = {10.15252/emmm.201707673},
  pmid    = {28855301},
  url     = {https://doi.org/10.15252/emmm.201707673}
}

@article{lessard2018-30341064,
  author  = {Lessard, C. B. and Malnik, S. L. and Zhou, Y. and Ladd, T. B. and Cruz, P. E. and Ran, Y. and Mahan, T. E. and Chakrabaty, P. and others},
  title   = {{High-affinity interactions and signal transduction between Aβ oligomers and TREM2}},
  journal = {EMBO molecular medicine},
  year    = {2018},
  doi     = {10.15252/emmm.201809027},
  pmid    = {30341064},
  url     = {https://doi.org/10.15252/emmm.201809027}
}

@article{lau2013-24014289,
  author  = {Lau, Pierre and Bossers, Koen and Janky, Rekin’s and Salta, Evgenia and Frigerio, Carlo Sala and Barbash, Shahar and Rothman, Roy and Sierksma, Annerieke S. R. and others},
  title   = {{Alteration of the microRNA network during the progression of Alzheimer's disease}},
  journal = {EMBO Molecular Medicine},
  year    = {2013},
  doi     = {10.1002/emmm.201201974},
  pmid    = {24014289},
  url     = {https://doi.org/10.1002/emmm.201201974}
}

@article{simone2018-29113975,
  author  = {Simone, R. and Balendra, R. and Moens, T. G. and Preza, E. and Wilson, K. M. and Heslegrave, A. and Woodling, N. S. and Niccoli, T. and others},
  title   = {{G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo}},
  journal = {EMBO molecular medicine},
  year    = {2018},
  doi     = {10.15252/emmm.201707850},
  pmid    = {29113975},
  url     = {https://doi.org/10.15252/emmm.201707850}
}

@article{xiang2016-27402340,
  author  = {Xiang, X. and Werner, G. and Bohrmann, B. and Liesz, A. and Mazaheri, F. and Capell, A. and Feederle, R. and Knuesel, I. and others},
  title   = {{TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance}},
  journal = {EMBO molecular medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201606370},
  pmid    = {27402340},
  url     = {https://doi.org/10.15252/emmm.201606370}
}

@article{suarezcalvet2018-30482868,
  author  = {Suárez-Calvet, M. and Capell, A. and MÁ, Araque Caballero and Morenas-Rodríguez, E. and Fellerer, K. and Franzmeier, N. and Kleinberger, G. and Eren, E. and others},
  title   = {{CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline}},
  journal = {EMBO molecular medicine},
  year    = {2018},
  doi     = {10.15252/emmm.201809712},
  pmid    = {30482868},
  url     = {https://doi.org/10.15252/emmm.201809712}
}

@article{umoh2018-29191947,
  author  = {Umoh, M. E. and Dammer, E. B. and Dai, J. and Duong, D. M. and Lah, J. J. and Levey, A. I. and Gearing, M. and Glass, J. D. and others},
  title   = {{A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain}},
  journal = {EMBO molecular medicine},
  year    = {2018},
  doi     = {10.15252/emmm.201708202},
  pmid    = {29191947},
  url     = {https://doi.org/10.15252/emmm.201708202}
}

@article{mattsson2025-41326715,
  author  = {Mattsson, Niklas and Karlsson, Linda and Tang, Weizhong and Blennow, Kaj and Zetterberg, Henrik and Bateman, Randall John and Schindler, Suzanne Elizabeth and Barthélemy, Nicolas R. and others},
  title   = {{Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid}},
  journal = {EMBO Molecular Medicine},
  year    = {2025},
  doi     = {10.1038/s44321-025-00348-7},
  pmid    = {41326715},
  url     = {https://doi.org/10.1038/s44321-025-00348-7}
}

@article{pierrot2013-23554170,
  author  = {Pierrot, N. and Tyteca, D. and D'auria, L. and Dewachter, I. and Gailly, P. and Hendrickx, A. and Tasiaux, B. and Haylani, L. E. and others},
  title   = {{Amyloid precursor protein controls cholesterol turnover needed for neuronal activity}},
  journal = {EMBO molecular medicine},
  year    = {2013},
  doi     = {10.1002/emmm.201202215},
  pmid    = {23554170},
  url     = {https://doi.org/10.1002/emmm.201202215}
}

@article{leuzy2022-34859598,
  author  = {Leuzy, A. and Mattsson-Carlgren, N. and Palmqvist, S. and Janelidze, S. and Dage, J. L. and Hansson, O.},
  title   = {{Blood-based biomarkers for Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2022},
  doi     = {10.15252/emmm.202114408},
  pmid    = {34859598},
  url     = {https://doi.org/10.15252/emmm.202114408}
}

@article{preman2024-39528861,
  author  = {Preman, Pranav and Moechars, Daan and Fertan, Emre and Wolfs, Leen and Serneels, Lutgarde and Shah, Disha and Lamote, Jochen and Poovathingal, Suresh and others},
  title   = {{APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia}},
  journal = {EMBO molecular medicine},
  year    = {2024},
  doi     = {10.1038/s44321-024-00162-7},
  pmid    = {39528861},
  url     = {https://doi.org/10.1038/s44321-024-00162-7}
}

@article{cheng2017-28356312,
  author  = {Cheng, Y. S. and Chen, Z. T. and Liao, T. Y. and Lin, C. and Shen, H. C. and Wang, Y. H. and Chang, C. W. and Liu, R. S. and others},
  title   = {{An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice}},
  journal = {EMBO molecular medicine},
  year    = {2017},
  doi     = {10.15252/emmm.201606666},
  pmid    = {28356312},
  url     = {https://doi.org/10.15252/emmm.201606666}
}

@article{mattsson2017-28743782,
  author  = {Mattsson, N. and Schöll, M. and Strandberg, O. and Smith, R. and Palmqvist, S. and Insel, P. S. and Hägerström, D. and Ohlsson, T. and others},
  title   = {{18 F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2017},
  doi     = {10.15252/emmm.201707809},
  pmid    = {28743782},
  url     = {https://doi.org/10.15252/emmm.201707809}
}

@article{lanterorodriguez2021-34725927,
  author  = {Lantero-Rodriguez, Juan and Snellman, Anniina and Benedet, Andrea L and Milà-Alomà, Marta and Camporesi, Elena and Montoliu-Gaya, Laia and Ashton, Nicholas J and Vrillon, Agathe and others},
  title   = {{P-tau235: a novel biomarker for staging preclinical Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202115098},
  pmid    = {34725927},
  url     = {https://doi.org/10.15252/emmm.202115098}
}

@article{delaney2021-33350588,
  author  = {Delaney, Conor and Farrell, Michael and Doherty, Colin P and Brennan, Kiva and O'Keeffe, Eoin and Greene, Chris and Byrne, Kieva and Kelly, Eoin and others},
  title   = {{Attenuated CSF-1R signalling drives cerebrovascular pathology}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202012889},
  pmid    = {33350588},
  url     = {https://doi.org/10.15252/emmm.202012889}
}

@article{fagan2009-20049742,
  author  = {Fagan, A. M. and Mintun, M. A. and Shah, A. R. and Aldea, P. and Roe, C. M. and Mach, R. H. and Marcus, D. and Morris, J. C. and others},
  title   = {{Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2009},
  doi     = {10.1002/emmm.200900048},
  pmid    = {20049742},
  url     = {https://doi.org/10.1002/emmm.200900048}
}

@article{hinrich2016-26902204,
  author  = {Hinrich, A. J. and Jodelka, F. M. and Chang, J. L. and Brutman, D. and Bruno, A. M. and Briggs, C. A. and James, B. D. and Stutzmann, G. E. and others},
  title   = {{Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides}},
  journal = {EMBO molecular medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201505846},
  pmid    = {26902204},
  url     = {https://doi.org/10.15252/emmm.201505846}
}

@article{lalli2021-f2e71f9d,
  author  = {Lalli, Giovanna and Schott, Jonathan M and Hardy, John and De Strooper, Bart},
  title   = {{Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?}},
  journal = {EMBO Molecular Medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202114781},
  url     = {https://doi.org/10.15252/emmm.202114781}
}

@article{guo2026-41807703,
  author  = {Guo, Shenrui and Jin, Hongfu and Sun, Hui and Huang, Shuo and Chen, Yuanyuan and Chang, Yuge and Zhang, Yu and Ding, Lin and others},
  title   = {{TDP-43 pathology triggers neuroinflammation and cognitive impairment by inducing microglial necroptosis}},
  journal = {EMBO Molecular Medicine},
  year    = {2026},
  doi     = {10.1038/s44321-026-00394-9},
  pmid    = {41807703},
  url     = {https://doi.org/10.1038/s44321-026-00394-9}
}

@article{levy2015-4d2d615e,
  author  = {Levy, Olivier and Calippe, Bertrand and Lavalette, Sophie and Hu, Shulong J and Raoul, William and Dominguez, Elisa and Housset, Michael and Paques, Michel and others},
  title   = {{Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age‐related macular degeneration}},
  journal = {EMBO Molecular Medicine},
  year    = {2015},
  doi     = {10.15252/emmm.201404524},
  url     = {https://doi.org/10.15252/emmm.201404524}
}